PMID: 3743863Aug 1, 1986Paper

Non-menstrual toxic shock syndrome. A case report and a review of non-menstrual toxic shock syndrome in Western Europe

European Journal of Obstetrics, Gynecology, and Reproductive Biology
J S VanderheydenJ Bal

Abstract

Having been confronted with a post-operative toxic shock syndrome, we made a study of European literature and were struck by the more favorable course the disease promptly took when penicillinase-resistant antibiotics were used. We suggest that a new case, based on bacteriological analysis and phagotyping of the offending organism and wound appearance, was prevented by us when immediate antibiotic treatment was given.

References

Jan 23, 1982·Lancet·R LeeE Baehler
Jun 10, 1983·Deutsche medizinische Wochenschrift·N BreuerE E Ohnhaus
May 1, 1983·American Journal of Obstetrics and Gynecology·G P Wager
May 21, 1983·British Medical Journal·M WhitbyP A Wright
Jul 31, 1982·British Medical Journal·J J DixeyM J de Saxe
Aug 26, 1983·JAMA : the Journal of the American Medical Association
Mar 12, 1982·JAMA : the Journal of the American Medical Association·P BartlettK A Wichterman
Jun 1, 1982·Annals of Internal Medicine·A L ReingoldC V Broome

❮ Previous
Next ❯

Citations

Feb 16, 2017·Clinical Drug Investigation·Nicholas Zareifopoulos, George Panayiotakopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.